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A B S T R A C T
Objective: Studies have shown some complementary therapies to be effective in the management of
diabetes and its comorbidities. The present study was conducted to evaluate the effect of an
aromatherapy extract on anxiety and fatigue in type 2 diabetic patients.
Methods: 60 type 2 diabetic patients were randomly assigned in two groups: patients in the intervention
group received bitter orange (Citrus aurantium) extract inhalation aromatherapy for three consecutive
nights before sleeping, whereas patients in the control group received usual care. Patients’ level of
anxiety and fatigue was recorded before and after intervention using Visual Analog Scale (VAS).
Results: The mean score of anxiety in patients in the intervention group before and after intervention
were 63.13  40.42 and 52.9  3.57, respectively (P < 0.001). The mean score of anxiety in patients in
control group before and after intervention were 56.73  39.52 and 56.6  3.93, respectively (P = 0.468).
The mean score of fatigue in patients in intervention group before and after intervention were
65.7  39.63 and 63  3.93, respectively. The mean score of fatigue in patients in control group before and
after intervention were 56.5  43.15 and 56.26  4.28, respectively (P = 0.436).
Conclusion: The use of bitter orange extract inhalation aromatherapy is a potentially effective
intervention to relive type 2 diabetics’ anxiety and fatigue. Further study in this regards are
recommended.
© 2019 Elsevier Ltd. All rights reserved.
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Over the past thirty years, the international community has
witnessed a 4-fold increase in diabetes [1]. In 2018, one in every 11
adults suffered from diabetes, of which 90% was type 2 diabetes
[1]. It is estimated that in the year 2035, approximately 592 million
people will have diabetes [2]. Diabetes is particularly common in
Asian countries [1]. The prevalence of diabetes in Iran was
evaluated between the years 2005 and 2011, and more than 4
million people in Iran were diagnosed with diabetes in 2011, a 35%
increase compared to 2005 [3]. Diabetes is the ninth leading cause
of death in the world, with cardiovascular disease is the leading
cause of death in these patients [1]. Weight gain, obesity, nutrition
and low-mobility lifestyle are some of the factors that increase the
prevalence of type 2 diabetes [1,2].* Corresponding author at: Qazvin university of Medical Science, 34917-36664,
Qazvin, Iran.
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2212-9588/© 2019 Elsevier Ltd. All rights reserved.Patients with type 2 diabetes face a number of co-morbid
problems as a result of their diabetes, including fatigue and anxiety
[4–6]. These problems can be extreme - the results of a study
conducted in 2016 showed that more than 90% of women and men
with type 2 diabetes expressed their anxiety in extreme range [7].
Some factors such as having a chronic disease, blood sugar
fluctuations and the inability to control it, the need for hospitali-
zation, complications of diabetes (including cardiovascular dis-
ease, nephropathy and retinopathy) and long-term treatment can
also lead to further anxiety in diabetics [8–12]. Fatigue may also be
more prevalent in diabetics, with the results of another study,
which examined fatigue in women with diabetes, showed that the
fatigue in this group of women is significantly higher than healthy
women [4]. Factors such as having a chronic disease, blood glucose
levels and hemoglobin A1C, sleep disorders and decreased activity
of daily life can cause fatigue in diabetic patients [13]. Anxiety and
fatigue in diabetic patients can also have significant side effects.
Disrupted daily functioning and decreased quality of life are often
due to fatigue [14] and inconsistency with disease, decreased
quality of life, and an increase in the risk of death can be associated
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anxiety in patients with type 2 diabetes have been studied and
recommendations to screen patients for these conditions have
been developed [17], our searches showed very few studies
examining strategies for the treatment or reduction of these
complications. In many cases, fatigue and anxiety in patients with
type 2 diabetes remains untreated and neglected.
Use of complementary and alternative medicine is increasing
globally for treatment of numerous conditions [18]. Aromatherapy
is one traditional methods of complementary medicine commonly
used in Iran [19]. Several studies have determined the positive
effects of aromatherapy on the reduction of fatigue and anxiety in
patients with diseases other than diabetes. For instance, a study of
the effects of aromatherapy treatment, using lavender oil, on the
anxiety of patients undergoing gastrointestinal surgery found that
aromatherapy, using lavender oil, significantly alleviated the
anxiety of these patients [20]. Asazawa et al. studied the effects
of aromatherapy treatment on the fatigue in women during
childbirth. The results of this study showed that aromatherapy
treatment is very effective in reducing fatigue in women during
childbirth [21]. Various extracts are used in aromatherapy, with
one of the more common extracts being bitter orange extract [19].
Bitter orange extract is originated from a herb [1,11] called Citrus
aurantium, commonly known as bitter orange. It is produced in the
Northern and Southern parts of Iran. Its essence is consisted of 35%
of different hydrocarbons, 47% of Terpene alcohols such as Linalool,Fig. 1. Patient’s selection and allocation Terpineol, Geraniol, Nerol, Flavonoid and all their acetates, 6% of
Nerolidol and 0.7%–1.1% of Indole [21] (Fig. 1).
Considering that aromatherapy treatment has been effective in
reducing the anxiety and fatigue of patients with different
diseases, it has been hypothesized that aromatherapy treatment
may have effects on reducing the anxiety and fatigue in diabetic
patients. However, there have been no studies of aromatherapy for
treatment of anxiety and fatigue in diabetic patients. Therefore, the
present study was conducted with the aim of studying the effects
of aromatherapy treatment, using bitter orange extract, on anxiety
and fatigue of patients with type 2 diabetes.
2. Material and methods
2.1. Sample and sampling method
The present clinical trial was conducted during July to October
2016. Subjects were recruited from patients who were referred to
Qazvin Velayat and Boali Sina hospitals in Iran. The sample consisted
of 60 patients, who were randomly allocated to intervention
(aromatherapy) and control groups. Randomization was performed
using a simple randomization method.
The inclusion criteria were: diagnosed as T2D, aged 30–65
years, and having anxiety and fatigue based on patients’
reports. Exclusion criteria were: any health crisis in the
subjects during the intervention, history of asthma andin intervention and control groups.
Table 1
Participants demographics characteristics.
Categories Aromatherapy Control group χ2a p
n (%) n (%)
Gender 4.44 0.108
Male 14 (46.7%) 8 (26.7%)
Female 16 (53.3%) 22 (73.3%)
Age (year) 1.329 0.514
30–49 5 (16.7%) 4 (13.3%)
50–59 7 (23.3%) 4 (13.3%)
60–65 18 (60%) 22 (73.3%)
Marital Status 0.483 0.785
Single 1 (3.3%) 1(3.3%)
Married 25 (83.3%) 23(76.6%)
Widower 4 (13.3%) 6(20%)
Divorced 0 (0%) 0(0%)
Education 2.20 0.698
Lower than middle school 27(90%) 28(93.3%)
High School 2(6.7%) 2(6.7%)
More than College 1(3.3%) 0(0%)






Full time job 1(3.3%) 3(10%)
Part time job 2(6.7%) 1(3.3%)
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and hypnotic drugs.
The sample size was determined using the following
sample size formula. In order to determine the sample size,
significance level (α(of 0.05 and statistical power (β-1) of 0.80
were considered from previous studies. After considering the
failure rate, the sample size was calculated as 30 subjects in
each group [22].
N = 1/1-f  2 (Z1-α/2 + Z1-β) 2 S2 / (m1-m2) 2
2.2. Instruments
1) A structured demographic checklist. This checklist included
patient’s age, sex, level of education, marital status and disease
duration.
2) Visual Analogue Scale (VAS) for assessing anxiety and fatigue:
VAS used in present study was 0 mm–100 mm scale is a10 cm
line, 10 cm long. The subjects were asked to mark a point on the
line that represented how they feel anxiety and fatigue at the
time. VAS is a valid and reliable measure for assessing the
intensity of anxiety and fatigue [23]. Patients’ anxiety and
fatigue was assessed by VAS before and after intervention.
2.3. Ethical considerations
This study was approved by the Ethical Committee of Medical
Research at Iran University of Medical Sciences. Data were
collected after the informed consent was obtained from the
subjects. This research project is taken from a thesis with the
ethical code of IR.IUMS.REC 1395.9311686017. Protocol of present
study was also assessed and approved by Iranian registry of clinical
trial (IRCT 2017011520145 N4).
2.4. Procedure
Patients in the intervention group, in addition to usual care,
received aromatherapy using bitter orange extract 20% concentra-
tion (Citrus aurantium 20%) inhalation. Patients inhaled eight drops
of bitter orange extract 20% before sleeping, and the cotton was
placed on the collar of their shirt until morning. The intervention
was conducted from 10 PM to 6 A M on three consecutive days. The
Bitter orange essence, produced by the Hegrat Essence Company
(Kashan, Iran), was used in present study. Patients in control group
received usual care.
2.5. Data analysis
The data were analyzed using the SPSS software version 22.
Demographic variables were analyzed using descriptive statistics
(mean, standard deviation and percentage). The homogeneity tests
of demographic variables in the aromatherapy and control groups
were performed using Chi-square test. Given not normal distribu-
tion of anxiety and fatigue, Mann-Whitney U test was used to
analyse the anxiety and fatigue level before and after the
intervention. P-value of less than 0.05 considered significant in
all test.
3. Results
The mean age of patients in the intervention group was
58.30  7.62 year, 46.7% of them were male, and 83.3% were
married. The mean age of patients in control group was
59.23  6.73, 26.7% of them were male, and 76.6% were married.There was no significant difference between the two groups in
terms of demographics characteristics (p > 0.05). Table . . .
showed the patients demographics characteristics in details
(Table 1).
The mean score of anxiety in patients in intervention group
before and after intervention were 63.13  40.42 and 52.9  3.57,
respectively. This decrease in anxiety level before and after
intervention was statistically significant (P < 0.001). The mean
score of anxiety in patients in control group before and after
intervention were 56.73  39.52 and 56.6  3.93, respectively
(P = 0.468) (Table 2). The mean score of fatigue in patients in
intervention group before and after intervention were 65.7  39.63
and 63  3.93, respectively. This decrease in fatigue level before
and after intervention was statistically significant (P < 0.014). The
mean score of fatigue in patients in control group before and after
intervention were 56.5  43.15 and 56.26  4.28, respectively
(P = 0.436) (Table 2).
4. Discussion
To our knowledge, this is the first study that has examined the
effect of inhalation aromatherapy on anxiety and fatigue in
patients with type 2 diabetes. The results of present study revealed
that inhalation aromatherapy with bitter orange extract as a
complementary and alternative therapy significantly reduced the
level of anxiety and fatigue in type 2 diabetic patients.
Anxiety is common syptom among diabetic patients. Anxiety in
this group of patients can cause several complications such as
tension, fear, depressed mood, cardiovascular and gastrointestinal
symptoms, insomnia, somatic symptoms, autonomic symptoms,
respiratory and genitourinary symptoms [24]. Management of
anxiety with nonpharmacological methods is important, particu-
larly in groups such as diabetics that may already be on multiple
medications. Patients who received aromatherapy in our study
reported lower levels of anxiety compared to those who received
the usual nursing care. Our literature searches did not show any
Table 2
Level of anxiety and fatigue before and after intervention in intervention and control groups.
Outcome measure Aromatherapy group(n=30) Control group(n=30) p z
Mean  SD Mean  SD
Anxiety (VAS) Score Before the intervention 0.468 0.726
After the intervention 63.13  40.42 56.7339.52
52.9  3.57 56.63.93
Fatigue (VAS) Score before and 65.739.63 56.543.15 0.436 0.778
after the study
633.93 56.264.28
Differences in Anxiety (VAS) Score before and after aromatherapy 10.23  9.92 3.23  5.48 <0.001 5.18
Differences in Fatigue(VAS) Score before and after aromatherapy 2.75.52 0.231.69 0.014 2.451
*Mann-Whitney Test.
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bitter orange extract on anxiety of type 2 diabetic patients.
However, studies on other groups of patients, with other extracts,
has shown similar findings. Nagafi et al., examined the effect of
aromatherapy on the anxiety of patients with myocardial
infarction [25]. Patients in Nagafi et al., study received inhalation
aromatherapy with lavender aroma twice a day for two subsequent
days. Similar to finding of the present study, results of Nagafi et al.,
study revealed that aromatherapy is an effective method to relieve
patient’s anxiety [25]. Barati et al., examined the effect of inhaling
rose water aromatherapy on anxiety in hemodialysis patients for 4
weeks. They used the state-trait anxiety inventory of Spielberger to
investigate the anxiety level of the patients. Similar to findings of
present study, results of Barati et al., study revealed that the
aromatherapy using rose water significantly alleviate the anxiety
of hemodialysis patients [26].
Fatigue is also common and distressing complaint among
diabetics. Fatigue may have a negatie impact on diabetics ability to
perform daily diabetes self-management tasks [27]. Management
of fatigue is therefore an important issue for improving diabetic’
clinical situations. The results of the present study also revealed
that using inhalation aromatherapy with bitter orange extract
significantly decreased the fatigue of patients with type 2 diabetes.
Our literature searches did not show any study that examined the
effects of inhalation aromatherapy with bitter orange extract on
fatigue of type2 diabetic patients. However, studies on the other
groups of patients showed similar findings. Sung-Hee et al.
examined the effects of aromatherapy inhalation on fatigue of
postpartum women. The results of Sung-Hee et al., study revealed
that aromatherapy is an effective intervention for alleviating
fatigue [28]. Muz & Taşc examined the effects of inhalation
aromatherapy on fatigue level of hemodialysis patients. Patients
in Muz & Taşc study received sweet orange and lavender oil
aromatherapy before going to bed every day for one month. Similar
to finding of present study, the results of Muz & Taşc study revealed
that inhalation aromatherapy is effective intervention for reliving
fatigue in hemodialysis patients [29].
5. Limitation
Using self-reports to examine the anxiety and fatigue is the
limitation of our study. Additionally, this study examined a specific
oil (bitter orange extract) and may not be generalisable to other
aromatherapy interventions.
6. Conclusion
Aromatherapy is a readily available and low cost intervention.
Side effects of this method are alsorare. Findings from this study
suggest that aromatherapy may be an effective intervention to
decrease the anxiety and fatigue in type 2 diabetic patients. It is
recommended that healthcare providers of diabetic patientsconsider nonpharmacological methods for management of anxiety
and fatigue. Further studies are strongly recommended, with time
of patients’ follow up after intervention increased.
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